检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]昆明医学院第二附属医院麻醉科,云南昆明650101
出 处:《昆明医学院学报》2010年第3期89-91,共3页Journal of Kunming Medical College
摘 要:目的探讨帕瑞昔布钠对于术后疼痛的治疗.方法80例ASAⅠ~Ⅱ级择期行胆囊切除术,按手术方式分为腹腔镜组(又分为Ⅰ、Ⅱ两组,每组n=20)和开腹组(又分为Ⅲ、Ⅳ两组,每组n=20),所有病人均采用全麻插管靶控全凭静脉麻醉,Ⅰ组、Ⅲ组术毕前10 min分别静脉给予帕瑞昔布钠(特耐)40 mg,Ⅱ组、Ⅳ组为对照组未给予.评估术后60 min疼痛强度(Prince-Henry评分)、镇痛补救措施、观察不良反应等.结果术后60 min内的各时段Ⅰ、Ⅱ组病人评分比较P<0.05;Ⅲ、Ⅳ组病人比较评分P>0.05,镇痛补救措施差异无统计学意义(P>0.05).在清醒室观察及术后24 h未发现病人消化道、凝血功能变化出现症状.结论术毕静脉给予帕瑞昔布钠(特耐)40 mg有一定镇痛作用,但是非甾体类抗炎镇痛药镇痛疗效较弱,尤其是有手术切口更不适合单独使用.Objective To investigate the efficacy of parecoxib for postoperative analgesia.Methods Eighty ASAⅠ-Ⅱ patients scheduled for laparoscopic cholecystectomy under general anesthesia were randomly divided into 2 groups(n=40 each) : laparoscope group and open group.Laparoscope group was divided into 2 subgroups(n=20 each):group Ⅰ and groupⅡ.Open group was also divided into 2 subgroups(n=20 each): group Ⅲ and group Ⅳ.A single dose of parecoxib 40 mg was given to patients 10 min before operation in group Ⅰ and Ⅲ.The patients in group Ⅱ and Ⅳ were served as control and received normal saline instead.The pain intensity 60 min after surgery was assessed using Prince-Henry score(PHS).The adverse reactions were observed.Results The PHS was significantly lower in group Ⅰ than in group Ⅱ(P0.05).The PHS was not significantly lower in The PHS was significantly lower in group Ⅰ than in group Ⅱ(P0.05).The allocation of extra analgetics was similar in groupⅠthan in groupⅡand in group Ⅲ than in groupⅣ(P0.05).No patient had the symptoms of gastrointestinal tract and changes in blood coagulation function during the observation in the recovery room and 24 h after surgery.Conclusion Parecoxib has analgesiceffect after cholecystectomy but the effect is not potent,so parecoxib is not suitable to use singly after operation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3